Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Styloid-Pterygoid Line: A Reproducible Anatomic Landmark for V3 Perineural Spread Biopsy.

AJNR. American journal of neuroradiology·2026
Same author

A new framework for pulmonary nodules: how terminology impacts management.

European radiology·2026
Same author

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates.

JHLT open·2025
Same author

Sarcopenia Predicts Outcomes After Lung Transplantation in Older Lung Transplant Candidates.

Annals of thoracic surgery short reports·2025
Same author

Spatial resolution enhancement using deep learning improves chest disease diagnosis based on thick slice CT.

NPJ digital medicine·2024
Same author

A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1).

Cancer imaging : the official publication of the International Cancer Imaging Society·2024

Related Experiment Video

Updated: Sep 8, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Imaging response assessment for oncology: An algorithmic approach.

Kathleen Ruchalski1, Rohit Dewan1, Victor Sai1

  • 1Department of Radiological Sciences, UCLA Los Angeles, CA, United States.

European Journal of Radiology Open
|June 13, 2022
PubMed
Summary

Assessing solid tumor treatment response in clinical trials relies on imaging criteria. While Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 is standard, specialized criteria like PERCIST, mRECIST, Choi, and PCWG3 address specific tumor types and treatments.

Keywords:
Cancer imagingRECISTRECIST, Response Evaluation Criteria in Solid TumorsResponse assessmentTreatment outcomes

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Related Experiment Videos

Last Updated: Sep 8, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Area of Science:

  • Oncology
  • Radiology
  • Clinical Trials

Background:

  • Imaging-based treatment response assessment is crucial for solid tumor clinical trials.
  • Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 is the established standard for this evaluation.
  • Limitations of RECIST 1.1 necessitate alternative and modified criteria for specific scenarios.

Purpose of the Study:

  • To review the landscape of imaging response criteria beyond RECIST 1.1.
  • To highlight specialized criteria tailored for different tumor types and imaging modalities.
  • To discuss the application of modified criteria in contemporary oncology research.

Main Methods:

  • Literature review of established and emerging imaging response criteria.
  • Categorization of criteria based on imaging modality, tumor type, and treatment approach.
  • Discussion of modifications and specific applications of non-RECIST criteria.

Main Results:

  • RECIST 1.1 is widely used but has limitations.
  • Several alternative criteria exist, including PERCIST for PET/CT.
  • Tumor-specific modifications (mRECIST, Choi criteria, PCWG3) and immunotherapy-specific criteria have been developed.

Conclusions:

  • A range of imaging response criteria beyond RECIST 1.1 are available and necessary.
  • The choice of criteria depends on imaging modality, tumor histology, and treatment type.
  • These diverse criteria enhance the accurate evaluation of treatment efficacy in clinical trials.